latestmarketingreports

  Postmenopausal Hormone Therapy Market size is estimated   to reach $46.5 billion   by 2027, growing   at a CAGR of 5.1%   during the forecast period 2022-2027. Postmenopausal Hormone Therapy includes medicines covering female hormones to take the place of the once the body no longer makes subsequent to menopause and is occasionally utilized to treat typical menopausal symptoms, inclusive of hot flashes and vaginal discomfort. Hormone therapy has also been confirmed to avert bone loss and decrease fractures in postmenopausal women. Atrophic vaginitis is normally associated with menopause and the related depleted levels of estrogen. Bazedoxifene is a novel SERM (Selective Estrogen Receptor Modulator) established by Wyeth Pharmaceuticals that is presently in phase III clinical trials for the avoidance and treatment of postmenopausal osteoporosis. Phytoestrogens are organic constituents from plants that bind to estrogen receptors in the body. Download Report Samp...

  Postmenopausal Hormone Therapy Market size is estimated   to reach $46.5 billion   by 2027, growing   at a CAGR of 5.1%   during the forecast period 2022-2027. Postmenopausal Hormone Therapy includes medicines covering female hormones to take the place of the once the body no longer makes subsequent to menopause and is occasionally utilized to treat typical menopausal symptoms, inclusive of hot flashes and vaginal discomfort. Hormone therapy has also been confirmed to avert bone loss and decrease fractures in postmenopausal women. Atrophic vaginitis is normally associated with menopause and the related depleted levels of estrogen. Bazedoxifene is a novel SERM (Selective Estrogen Receptor Modulator) established by Wyeth Pharmaceuticals that is presently in phase III clinical trials for the avoidance and treatment of postmenopausal osteoporosis. Phytoestrogens are organic constituents from plants that bind to estrogen receptors in the body. Download Report Samp...